Show Summary Details
- Title Pages
- List of Figures and Tables
- Preface
- Acknowledgments
- Introduction
- 1 From Conception to Commercial Success
- 2 A Limitation on the Patent Right to Exclude: An Introduction to International Exhaustion
- 3 An Introduction to TRIPS
- 4 Freedom under TRIPS: India as an Example
- 5 Compulsory Licenses under TRIPS: An Introduction
- 6 Compulsory License Case Study: An Introduction to Competing Patent Perspectives
- 7 Complicated Compulsory Licenses: The Waiver/Article 31bis “Solution”
- 8 An Overview of “TRIPS-Plus” Standards
- 9 Beyond Patents: Protecting Drugs through Regulatory Law
- 10 Suspensions of In-Transit “Generic” Drugs: A Case Study of Competing Perspectives
- 11 A History of Access to Medicine Through the Lens of Patent Perspectives
- 12 Looking Toward the Future
- Appendix A: Selected TRIPS Provisions
- Appendix B: Declaration on the Trips Agreement and Public Health
- Appendix C: Draft Ministerial Declaration
- Appendix D: Draft Ministerial Declaration
- Appendix E: Glossary of Terms
- Index
(p.vii) List of Figures and Tables
(p.vii) List of Figures and Tables
- Source:
- Access to Medicine in the Global Economy
- Publisher:
- Oxford University Press
Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .
- Title Pages
- List of Figures and Tables
- Preface
- Acknowledgments
- Introduction
- 1 From Conception to Commercial Success
- 2 A Limitation on the Patent Right to Exclude: An Introduction to International Exhaustion
- 3 An Introduction to TRIPS
- 4 Freedom under TRIPS: India as an Example
- 5 Compulsory Licenses under TRIPS: An Introduction
- 6 Compulsory License Case Study: An Introduction to Competing Patent Perspectives
- 7 Complicated Compulsory Licenses: The Waiver/Article 31bis “Solution”
- 8 An Overview of “TRIPS-Plus” Standards
- 9 Beyond Patents: Protecting Drugs through Regulatory Law
- 10 Suspensions of In-Transit “Generic” Drugs: A Case Study of Competing Perspectives
- 11 A History of Access to Medicine Through the Lens of Patent Perspectives
- 12 Looking Toward the Future
- Appendix A: Selected TRIPS Provisions
- Appendix B: Declaration on the Trips Agreement and Public Health
- Appendix C: Draft Ministerial Declaration
- Appendix D: Draft Ministerial Declaration
- Appendix E: Glossary of Terms
- Index
